CME Group (NASDAQ:CME) CEO Sells $10,447,850.00 in Stock

CME Group Inc. (NASDAQ:CME) CEO Terrence Duffy sold 35,000 shares of the stock in a transaction dated Friday, May 15th. The stock was sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the sale, the chief executive officer owned 55,630 shares in the company, valued at approximately $16,606,111.30. This trade represents a 38.62% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

CME Group Stock Performance

CME opened at $290.12 on Thursday. The business’s 50 day moving average is $296.96 and its 200-day moving average is $288.93. The stock has a market cap of $105.13 billion, a PE ratio of 24.75, a price-to-earnings-growth ratio of 3.66 and a beta of 0.23. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a twelve month low of $257.17 and a twelve month high of $329.16.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 EPS for the quarter, beating analysts’ consensus estimates of $3.11 by $0.25. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The company had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.77 billion. During the same period last year, the company earned $2.80 earnings per share. The company’s quarterly revenue was up 14.5% compared to the same quarter last year. On average, analysts predict that CME Group Inc. will post 12.26 earnings per share for the current year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Tuesday, June 9th will be issued a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date is Tuesday, June 9th. CME Group’s dividend payout ratio (DPR) is presently 44.37%.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

• Neutral Sentiment: Recent market commentary says the stock’s weakness looks consistent with profit-taking after CME’s strong first-quarter results, which included record revenue and better-than-expected earnings. That means investors may be locking in gains after the company set a high bar for continued performance.
• Neutral Sentiment: Macro expectations are also shaping the move: traders are pricing out Federal Reserve rate cuts in 2026, and CME’s business depends heavily on derivatives and rate-volatility activity. If rate uncertainty stabilizes, trading volumes can cool, which may be weighing on the shares.
• Neutral Sentiment: CME recently filed routine annual-meeting shareholder materials, and its adjourned Class B proposals after a quorum shortfall. These governance updates are not likely to change the business outlook, but they can keep investor attention on voting and corporate structure issues. Article Title
• Neutral Sentiment: There was also a notable insider sale by CEO Terrence Duffy and another sale by Hilda Harris Piell. Insider selling often hurts sentiment, but it appears more like a cautionary signal than a direct fundamental warning. Article Title
• Negative Sentiment: Competition in emerging compute-linked futures is also drawing attention, with ICE planning its own computing-power futures market while CME is pursuing similar product expansion. That suggests CME may face pressure to defend its growth opportunities in a new niche. Article Title

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of CME. Empowered Funds LLC increased its holdings in shares of CME Group by 11.5% during the 1st quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock worth $2,660,000 after purchasing an additional 1,037 shares during the period. Marshall Wace LLP boosted its position in shares of CME Group by 103.1% during the 2nd quarter. Marshall Wace LLP now owns 3,692 shares of the financial services provider’s stock valued at $1,018,000 after acquiring an additional 121,707 shares in the last quarter. Federated Hermes Inc. boosted its position in shares of CME Group by 1,325.2% during the 2nd quarter. Federated Hermes Inc. now owns 23,572 shares of the financial services provider’s stock valued at $6,497,000 after acquiring an additional 21,918 shares in the last quarter. Nebula Research & Development LLC acquired a new stake in shares of CME Group during the 2nd quarter valued at about $992,000. Finally, The Manufacturers Life Insurance Company boosted its position in shares of CME Group by 2.6% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 287,876 shares of the financial services provider’s stock valued at $79,344,000 after acquiring an additional 7,397 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the stock. UBS Group reaffirmed a “neutral” rating and issued a $310.00 price objective on shares of CME Group in a research note on Friday, February 6th. Jefferies Financial Group decreased their price objective on shares of CME Group from $356.00 to $349.00 and set a “buy” rating for the company in a research note on Thursday, April 9th. Raymond James Financial raised their price objective on shares of CME Group from $310.00 to $320.00 and gave the stock an “outperform” rating in a research note on Monday, April 6th. Morgan Stanley decreased their price objective on shares of CME Group from $362.00 to $353.00 and set an “overweight” rating for the company in a research note on Thursday, April 23rd. Finally, Erste Group Bank raised shares of CME Group from a “hold” rating to a “strong-buy” rating in a research note on Thursday, March 5th. Two equities research analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $305.29.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.